Comprehensive long-term management program for asthma : Effect on outcomes in adult African-Americans.
To determine if a comprehensive long-term management program, emphasizing inhaled corticosteroids and patient education, would improve outcomes in adult African-American asthmatics a nonrandomized control trial with a 2-year intervention was performed in a university-based clinic.
Inclusion criteria consisted of (>5) emergency department (ED) visits or hospitalizations (=2) during the previous 2 years.
Intervention patients were volunteers ; a comparable control group was identified via chart review at hospitals within the same area and time period as the intervention patients.
Individualized doses of beclomethasone with a spacer, inhaled albuterol « as needed, » and crisis prednisone were the primary therapies.
Environmental control, peak flow monitoring, and a partnership with the patient were emphasized.
Detailed patient education was an integral part of management.
Control patients received usual care from local physicians.
ED visits and hospitalizations for 2 years before and 2 years during the intervention period were compared.
Quality of life (QOL) measurements were made at baseline and every 6 months in the intervention group.
Study group (n=21) had a significant reduction in ED visits (2.3 ± 0.2 pre-intervention versus 0.6 ± 0.2 post-intervention ; P=0.0001).
Control group (n=18) did not have a significant change in ED visits during the 2-year post-intervention period (2.6 ± 0.2 pre-intervention versus 2.0 ± 0.2 post-intervention ; P=0.11). (...)
Mots-clés Pascal : Asthme, Traitement, Chimiothérapie, Corticostéroïde, Aérosol doseur, Association, Education sanitaire, Evaluation, Long terme, Evolution, Africain, Américain, Etude comparative, Homme, Appareil respiratoire pathologie, Bronchopneumopathie obstructive
Mots-clés Pascal anglais : Asthma, Treatment, Chemotherapy, Corticosteroid, Aerosol batcher, Association, Health education, Evaluation, Long term, Evolution, African, American, Comparative study, Human, Respiratory disease, Obstructive pulmonary disease
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 96-0321725
Code Inist : 002B11B. Création : 10/04/1997.